Biotech milestones

Under the current Chapter 20 rules for the London Stock Exchange, companies must satisfy the listing authorities that they have met one of the following rules:

• "If it is a company whose activities are mainly the research and development of pharmaceutical products, having at least two drugs in clinical trial under internationally accepted regulatory scrutiny;"...